A Novo Nordisk representative wrote in an email that the drugmaker anticipates “ongoing offer disruption” for the people a few doses as need continues to outpace generation. the business didn't have an estimate for how long they are going to continue to Restrict Those people doses. We hope that our six+ years of working with the NHS and creati